Novartis Malaysia's Breast Cancer Program Earns Regional Recognition

By: Women Entrepreneurs Review Team | Tuesday, 11 August 2026

Novartis Malaysia’s Living Well Living Longer (LWLL), a breast cancer survivorship program, has earned recognition at four regional industry award platforms in 2026 for its efforts to support women beyond diagnosis and treatment.

The initiative was created in collaboration with healthcare professionals, patient advocacy organizations and breast cancer survivors. It brings together three key components: the Living Well, Living Longer Coffee Table Book, the ICanCare app and Gift of Time patient workshops.

Together, these initiatives offer reliable information, patient navigation and psychosocial support through an integrated survivorship framework designed for women in Malaysia.

Novartis Malaysia said LWLL was introduced to address gaps in post-treatment care, particularly the need for accessible health information and continued psychosocial support as women adjust to life after breast cancer treatment.

By combining educational resources, digital tools and community-based support, LWLL complements clinical care and addresses the practical and emotional challenges associated with life after treatment, it added.

Key Highlights:

• LWLL has been recognized across four regional award platforms in 2026 for supporting breast cancer survivors
• The ICanCare app has recorded more than 6,000 downloads since its launch
• Demand for psychosocial support has increased by 250%, while workshop bookings rose 133%

Since its launch, the ICanCare app has recorded more than 6,000 downloads, with more than 50 per cent of users actively engaging with the platform.

Demand for psychosocial support has increased by 250 per cent, while Gift of Time workshop bookings have risen 133 per cent year on year.

Sanjeev Balachandran, country president of Novartis Malaysia, Brunei and Asia emerging markets, said the initiative was developed in recognition that breast cancer's impact can extend beyond treatment, leaving women to face ongoing emotional, practical and informational challenges.

The recognition spans patient advocacy, healthcare communications and purpose-driven storytelling across four regional award programs, he said.

This reflects the range of work undertaken through the survivorship initiative and its collaboration with healthcare professionals, advocacy groups and patients.

The recognition highlights the growing importance of survivorship care in breast cancer treatment. By focusing on life after treatment, LWLL aims to help women regain confidence, access reliable information and receive continued emotional support.

Novartis Malaysia said the initiative will continue to evolve through collaboration with healthcare professionals, patient groups and survivors. These partnerships are expected to strengthen survivorship support and address the changing needs of women living beyond breast cancer.

Through its combination of digital resources, educational initiatives and community support, LWLL demonstrates the role of integrated survivorship programs in helping women navigate the physical, emotional and practical challenges that can continue after cancer treatment.